
    
      Ureteral stent (US) has been as essential tool in the urologist's surgeries and is useful
      instruments that its indications increase due to new stent technologies and improvement of
      patient's comfort.

      US associated with discomfort complications that include lower urinary tract symptoms (LUTS)
      as frequency, urgency, dysuria, incomplete emptying, flanks and suprapubic's pain,
      incontinence, hematuria, movement of stent, infection and encrustation of stent. US related
      symptoms are as same as LUTS due to benign prostate hyperplasia and overactive bladder which
      relieve with alpha-blockers and anticholinergic. The purpose of our study is to investigate
      the effect of terazosin and tolterodine lonely and together in comparison of placebo on US
      related symptoms.

      The investigators study will be done prospectively. The patients who underwent indwelling
      Double-j stent distributed into four groups: 1)receive placebo 2)receive terazosin 2mg twice
      3)receive tolterodine 2mg daily 4) receive terazosin 2mg twice and tolterodine 2mg daily. All
      of the patients receive prophylactic antibiotic and on demand analgesic. After entrance to
      study, they fulfill the International Prostatic Symptoms Score (IPSS) and Visual Analog Scale
      (VAS) on the before indwelling US, two weeks after indwelling US and US removal time, then
      the investigators will evaluate the drug's effect on US related symptoms.
    
  